Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2656 AL 2670

Justice for Placebo: Placebo Effect in Clinical Trials and Everyday Practice

Knezevic NN, Sic A, Worobey S, Knezevic E.

Medicines (Basel). 2025 Feb 24;12(1):5. doi: 10.3390/medicines12010005.

Metabolomics in Parkinson's Disease and Correlation with Disease State

Ostrakhovitch EA, Ono K, Yamasaki TR.

Metabolites. 2025 Mar 18;15(3):208. doi: 10.3390/metabo15030208.

Exploring the Immunological Role of the Microbial Composition of the Appendix and the Associated Risks of Appendectomies

Islam T, Sagor MS, Tamanna NT, Bappy MKI, Danishuddin, Haque MA, Lackner M.

J Pers Med. 2025 Mar 14;15(3):112. doi: 10.3390/jpm15030112.

Alzheimer's, Parkinson's, Frontotemporal Lobar Degeneration, and Amyotrophic Lateral Sclerosis Start in Pediatric Ages: Ultrafine Particulate Matter and Industrial Nanoparticles Are Key in the Early-Onset Neurodegeneration: Time to Invest in Preventive Medicine

Calderón-Garcidueñas L, González-Maciel A, Reynoso-Robles R, Cejudo-Ruiz FR, Silva-Pereyra HG, Gorzalski A, Torres-Jardón R.

Toxics. 2025 Feb 28;13(3):178. doi: 10.3390/toxics13030178.

The Effects of Air Pollution on Neurological Diseases: A Narrative Review on Causes and Mechanisms

Lane M, Oyster E, Luo Y, Wang H.

Toxics. 2025 Mar 13;13(3):207. doi: 10.3390/toxics13030207.

Near-Infrared Stimulation in Psychiatry Disorders: A Systematic Review of Efficacy and Biological Mechanisms

Woźniak J, Pazdrak M, Domanasiewicz A, Kaźmierski J.

NeuroSci. 2025 Mar 17;6(1):26. doi: 10.3390/neurosci6010026.

Comparative efficacy of Mucuna pruriens and conventional levodopa in Parkinson's disease: a randomized controlled trial on pharmacokinetics and clinical perspectives from Asia

Boonmongkol T, Phokaewvarangkul O, Vimolmangkang S, Wattanavijitkul T, Komenkul V, Bhidayasiri R.

J Neural Transm (Vienna). 2025 Nov;132(11):1673-1683. doi: 10.1007/s00702-025-02914-2. Epub 2025 Mar 26.

Correction: Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease

Rangasamy SB, Dasarathi S, Pahan P, Jana M, Pahan K.

J Neuroimmune Pharmacol. 2025 Mar 26;20(1):28. doi: 10.1007/s11481-025-10189-3.

Management of Parkinson's disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching

Isaacson SH, Nasrallah H, Pahwa R, Alva G, Kremens D, Stahl SM.

Expert Opin Pharmacother. 2025 Apr;26(6):707-717. doi: 10.1080/14656566.2025.2481205. Epub 2025 Mar 27.

Predictors of Informal Caregiver Burden in Parkinson's Disease: A Systematic Review

Lesley R, Simpson J, Dale M, Eccles F, Lock S, Gunn S.

West J Nurs Res. 2025 Jun;47(6):524-543. doi: 10.1177/01939459251327968. Epub 2025 Mar 26.

Myelopathic motor symptoms overlaying Parkinson's disease

Groves J, Mallon DH, Borg A, Zaidman N, Foltynie T, Limousin P, Mehta AR, Korlipara LVP.

Pract Neurol. 2025 Sep 12;25(5):479-482. doi: 10.1136/pn-2025-004546.

Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson's Disease

Yaribash S, Mohammadi K, Sani MA.

Cell Mol Neurobiol. 2025 Mar 26;45(1):30. doi: 10.1007/s10571-025-01544-2.

Understanding disrupted motivation in Parkinson's disease through a value-based decision-making lens

Le Heron C, Morris LA, Manohar S.

Trends Neurosci. 2025 Apr;48(4):297-311. doi: 10.1016/j.tins.2025.02.008. Epub 2025 Mar 25.

GLP-1 receptor expression and Parkinson's disease: Reassessing the link

Xu QH, Wang C.

Parkinsonism Relat Disord. 2025 Jun;135:107799. doi: 10.1016/j.parkreldis.2025.107799. Epub 2025 Mar 19.

Revisiting the association between REM sleep behavior disorder and Parkinson's disease progression

Wu XT, Xu QH.

Parkinsonism Relat Disord. 2025 Aug;137:107801. doi: 10.1016/j.parkreldis.2025.107801. Epub 2025 Mar 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias